News Breathing space for GSK as Mylan's Advair copy rejected Stay of execution for ageing blockbuster
News Mylan recalls 81,000 EpiPens after reports of failures Recall follows two reports that allergy injection device failed.
News A re-brand for US generics and biosimilars sector Body will campaign to "Keep Medicines in Reach"
News Use generic alternatives to Seretide and save millions, advi... Earlier use of montelukast could save NHS millions, says NICE.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.